These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36308892)

  • 1. Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study.
    Zolopa C; Brothers TD; Leclerc P; Mary JF; Morissette C; Bruneau J; Hyshka E; Martin NK; Larney S
    Int J Drug Policy; 2022 Dec; 110():103894. PubMed ID: 36308892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia.
    Roxburgh A; Livingston M; Dietze P; Nielsen S; Cogger S; Bartlett M; Day C; Latimer J; Jauncey M; Clark N
    Public Health; 2023 Nov; 224():90-97. PubMed ID: 37742585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Montreal's supervised consumption sites on injection-related infections among people who inject drugs: An interrupted time series.
    Lim J; Panagiotoglou D
    PLoS One; 2024; 19(8):e0308482. PubMed ID: 39190638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interrupted time series analysis of trends in opioid-related emergency department visits from pre-COVID-19 pandemic to pandemic, from the Canadian Hospitals Injury Reporting and Prevention Program.
    Yao X; McFaull SR; Champagne AS; Thompson W
    BMC Public Health; 2023 Aug; 23(1):1483. PubMed ID: 37537534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the COVID-19 pandemic on access to supervised consumption programs.
    Gubskaya E; Kennedy MC; Hayashi K; Cui Z; Milloy MJ; Kerr T
    Subst Abuse Treat Prev Policy; 2023 Mar; 18(1):16. PubMed ID: 36899417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis.
    Kennedy MC; Hayashi K; Milloy MJ; Compton M; Kerr T
    Addiction; 2022 Apr; 117(4):986-997. PubMed ID: 34854162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using synthetic controls to estimate the population-level effects of Ontario's recently implemented overdose prevention sites and consumption and treatment services.
    Panagiotoglou D; Lim J
    Int J Drug Policy; 2022 Dec; 110():103881. PubMed ID: 36274565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The estimated costs and benefits of a hypothetical supervised consumption site in Providence, Rhode Island.
    Chambers LC; Hallowell BD; Zang X; Rind DM; Guzauskas GF; Hansen RN; Fuchs N; Scagos RP; Marshall BDL
    Int J Drug Policy; 2022 Oct; 108():103820. PubMed ID: 35973341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada.
    Allen ST; O'Rourke A; Johnson JA; Cheatom C; Zhang Y; Delise B; Watkins K; Reich K; Reich R; Lockett C
    Ann Med; 2022 Dec; 54(1):2692-2700. PubMed ID: 36168975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada.
    Cassie R; Hayashi K; DeBeck K; Milloy MJ; Cui Z; Strike C; West J; Kennedy MC
    Harm Reduct J; 2022 Nov; 19(1):126. PubMed ID: 36401299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone.
    Kline A; Williams JM; Steinberg ML; Mattern D; Chesin M; Borys S; Chaguturu V
    J Subst Use Addict Treat; 2023 Jun; 149():209028. PubMed ID: 37003539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USA.
    Zang X; Walley AY; Chatterjee A; Kimmel SD; Morgan JR; Murphy SM; Linas BP; Nolen S; Reilly B; Urquhart C; Schackman BR; Marshall BDL
    Addiction; 2023 Dec; 118(12):2413-2423. PubMed ID: 37640687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
    Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M
    Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supervised consumption site enables cost savings by avoiding emergency services: a cost analysis study.
    Khair S; Eastwood CA; Lu M; Jackson J
    Harm Reduct J; 2022 Mar; 19(1):32. PubMed ID: 35346223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the population-level effects of overdose prevention sites and supervised consumption sites in British Columbia, Canada: Controlled interrupted time series.
    Panagiotoglou D
    PLoS One; 2022; 17(3):e0265665. PubMed ID: 35316284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia.
    O'Rourke A; White RH; Park JN; Rodriguez K; Kilkenny ME; Sherman SG; Allen ST
    Harm Reduct J; 2019 Aug; 16(1):51. PubMed ID: 31470864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions.
    Bouck Z; Scheim AI; Gomes T; Ling V; Caudarella A; Werb D
    Int J Drug Policy; 2022 Jun; 104():103680. PubMed ID: 35447476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
    Notta D; Black B; Chu T; Joe R; Lysyshyn M
    Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the national stay-at-home order on emergency department visits for suspected opioid overdose during the first wave of the COVID-19 pandemic.
    Root ED; Slavova S; LaRochelle M; Feaster DJ; Villani J; Defiore-Hyrmer J; El-Bassel N; Ergas R; Gelberg K; Jackson R; Manchester K; Parikh M; Rock P; Walsh SL
    Drug Alcohol Depend; 2021 Nov; 228():108977. PubMed ID: 34598100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.